Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists on the 16th St. Gallen International Breast Cancer Conference (Vienna 2019).

Untch M, Thomssen C, Bauerfeind I, Braun M, Brucker SY, Felberbaum R, Hagemann F, Haidinger R, Hönig A, Huober J, Jackisch C, Kolberg HC, Kolberg-Liedtke C, Kühn T, Lüftner D, Maass N, Reimer T, Schneeweiss A, Schumacher-Wulf E, Schütz F, Thill M, Wuerstlein R, Fasching PA, Harbeck N.

Geburtshilfe Frauenheilkd. 2019 Jun;79(6):591-604. doi: 10.1055/a-0897-6457. Epub 2019 Jun 14.

2.

Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.

Leinert E, Schwentner L, Blettner M, Wöckel A, Felberbaum R, Flock F, Kühn T, Denkinger MD, Janni W, Kreienberg R, Singer S; BRENDA Study Group.

Breast J. 2019 May;25(3):386-392. doi: 10.1111/tbj.13231. Epub 2019 Apr 3.

PMID:
30945393
3.

Complete study demonstrating the absence of rhabdovirus in a distinct Sf9 cell line.

Hashimoto Y, Macri D, Srivastava I, McPherson C, Felberbaum R, Post P, Cox M.

PLoS One. 2017 Apr 19;12(4):e0175633. doi: 10.1371/journal.pone.0175633. eCollection 2017.

4.

Takotsubo Syndrome After Cardiopulmonary Resuscitation During Emergency Cesarean Delivery.

Kraft K, Graf M, Karch M, Felberbaum R.

Obstet Gynecol. 2017 Mar;129(3):521-524. doi: 10.1097/AOG.0000000000001850.

PMID:
28178047
5.

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients.

Fehr MK, Welter J, Sell W, Jung R, Felberbaum R.

Curr Oncol. 2016 Dec;23(6):e576-e582. doi: 10.3747/co.23.3200. Epub 2016 Dec 21.

6.

Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II.

Stüber T, van Ewijk R, Diessner J, Kühn T, Flock F, Felberbaum R, Blettner M, Kreienberg R, Janni W, Wöckel A, Singer S, Schwentner L.

Breast Cancer. 2017 Mar;24(2):281-287. doi: 10.1007/s12282-016-0701-8. Epub 2016 May 19.

PMID:
27193566
7.

Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.

Schwentner L, Van Ewijk R, Kühn T, Flock F, Felberbaum R, Blettner M, Kreienberg R, Janni W, Wöckel A, Singer S.

Support Care Cancer. 2016 Jun;24(6):2759-66. doi: 10.1007/s00520-016-3088-3. Epub 2016 Jan 27.

PMID:
26816089
8.

The course of psychiatric co-morbidity in patients with breast cancer--results from the prospective multi-centre BRENDA II study.

Singer S, Schwentner L, van Ewijk R, Blettner M, Wöckel A, Kühn T, Felberbaum R, Flock F, Janni W; BRENDA Study Group.

Psychooncology. 2016 May;25(5):590-6. doi: 10.1002/pon.3978. Epub 2015 Sep 11.

PMID:
26361249
9.

Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II.

Singer S, Blettner M, Kreienberg R, Janni W, Wöckel A, Kühn T, Felberbaum R, Flock F, Schwentner L; BRENDA II study group.

Breast Care (Basel). 2015 Apr;10(2):95-100. doi: 10.1159/000381933.

10.

The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors.

Felberbaum RS.

Biotechnol J. 2015 May;10(5):702-14. doi: 10.1002/biot.201400438. Epub 2015 Mar 20. Review.

PMID:
25800821
11.

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability.

Feshchenko E, Rhodes DG, Felberbaum R, McPherson C, Rininger JA, Post P, Cox MM.

BMC Biotechnol. 2012 Oct 30;12:77. doi: 10.1186/1472-6750-12-77.

12.

Comparison of in vitro- and chorioallantoic membrane (CAM)-culture systems for cryopreserved medulla-contained human ovarian tissue.

Isachenko V, Mallmann P, Petrunkina AM, Rahimi G, Nawroth F, Hancke K, Felberbaum R, Genze F, Damjanoski I, Isachenko E.

PLoS One. 2012;7(3):e32549. doi: 10.1371/journal.pone.0032549. Epub 2012 Mar 30.

13.

Desumoylation of the endoplasmic reticulum membrane VAP family protein Scs2 by Ulp1 and SUMO regulation of the inositol synthesis pathway.

Felberbaum R, Wilson NR, Cheng D, Peng J, Hochstrasser M.

Mol Cell Biol. 2012 Jan;32(1):64-75. doi: 10.1128/MCB.05878-11. Epub 2011 Oct 24.

14.

Incidence of testicular malignancies and correlation to risk factors in a TESE population of subfertile men.

Banz-Jansen C, Nikorowitsch C, Drechsler T, Felberbaum R, Schmutzler A, Diedrich K, Finas D.

Arch Gynecol Obstet. 2012 Jan;285(1):247-53. doi: 10.1007/s00404-011-1938-2. Epub 2011 Jun 5.

PMID:
21643980
15.

Assisted reproduction: what factors interfere in the professional's decisions? Are single women an issue?

Záchia S, Knauth D, Goldim JR, Chachamovich JR, Chachamovich E, Paz AH, Felberbaum R, Crosignani P, Tarlatzis BC, Passos EP.

BMC Womens Health. 2011 May 31;11:21. doi: 10.1186/1472-6874-11-21.

16.

Ovarian stimulation: from basic science to clinical application.

Ludwig M, Felberbaum RE, Diedrich K, Lunenfeld B.

Reprod Biomed Online. 2011 Feb;22 Suppl 1:S3-16. doi: 10.1016/S1472-6483(11)60003-5.

PMID:
21575847
17.

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.

Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, Fischer D, Sommer HL, Conrad B, Ortmann O, Fehm T, Rezai M, Mehta K, Loibl S; German Breast Group Investigators.

J Clin Oncol. 2011 Jun 10;29(17):2334-41. doi: 10.1200/JCO.2010.32.5704. Epub 2011 May 2.

PMID:
21537042
18.

Concentrations of inflammatory cytokines and the outcome in ICSI cycles.

Asimakopoulos B, Demirel C, Felberbaum R, Waczek S, Nikolettos N, Köster F, Al-Hasani S, Diedrich K.

In Vivo. 2010 Jul-Aug;24(4):495-500.

PMID:
20668315
19.

Intrafollicular and circulating concentrations of leptin do not predict the outcome in IVF-ICSI cycles.

Asimakopoulos B, Koster F, Felberbaum R, Tripsiannis G, Caglar GS, Nikolettos N, Al-Hasani S, Diedrich K.

Reprod Sci. 2009 Jan;16(1):113-9. doi: 10.1177/1933719108324139.

PMID:
19144893
20.

Multiple pregnancies after assisted reproduction--international comparison.

Felberbaum RE.

Reprod Biomed Online. 2007;15 Suppl 3:53-60.

PMID:
18598610
21.

Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE.

Andersen AN, Goossens V, Ferraretti AP, Bhattacharya S, Felberbaum R, de Mouzon J, Nygren KG; European IVF-monitoring (EIM) Consortium; European Society of Human Reproduction and Embryology (ESHRE).

Hum Reprod. 2008 Apr;23(4):756-71. doi: 10.1093/humrep/den014. Epub 2008 Feb 14.

PMID:
18281243
22.

Ulp2 and the DNA damage response: desumoylation enables safe passage through mitosis.

Felberbaum R, Hochstrasser M.

Cell Cycle. 2008 Jan 1;7(1):52-6. Epub 2007 Oct 28. Review.

PMID:
18196960
23.
24.

The Ulp2 SUMO protease is required for cell division following termination of the DNA damage checkpoint.

Schwartz DC, Felberbaum R, Hochstrasser M.

Mol Cell Biol. 2007 Oct;27(19):6948-61. Epub 2007 Jul 30.

25.

Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE.

Andersen AN, Goossens V, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG.

Hum Reprod. 2007 Jun;22(6):1513-25. Epub 2007 Apr 30.

PMID:
17470881
26.

Cell-specific enhancement of liposomal transfection by steroids in steroid receptor expressing cells.

Köster F, Schröder A, Finas D, Hauser C, Diedrich K, Felberbaum R.

Int J Mol Med. 2006 Dec;18(6):1201-5.

PMID:
17089027
27.

Epidural anaesthesia for labour: does it influence the mode of delivery?

Ros A, Felberbaum R, Jahnke I, Diedrich K, Schmucker P, Hüppe M.

Arch Gynecol Obstet. 2007 Apr;275(4):269-74. Epub 2006 Sep 20.

PMID:
17021773
28.

Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol.

Asimakopoulos B, Köster F, Felberbaum R, Al-Hasani S, Diedrich K, Nikolettos N.

Hum Reprod. 2006 Dec;21(12):3091-5. Epub 2006 Sep 27.

PMID:
17008327
29.

On the benefit of assisted reproduction techniques, a comparison of the USA and Europe.

Nygren K, Andersen AN, Felberbaum R, Gianaroli L, de Mouzon J; ESHRE's European IVF Monitoring (EIM).

Hum Reprod. 2006 Aug;21(8):2194. No abstract available.

PMID:
16887926
30.

GnRH agonists and antagonists in assisted reproduction: pregnancy rate.

Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K.

Reprod Biomed Online. 2006 Jul;13(1):84-7.

PMID:
16820115
31.

Modification of proteins by ubiquitin and ubiquitin-like proteins.

Kerscher O, Felberbaum R, Hochstrasser M.

Annu Rev Cell Dev Biol. 2006;22:159-80. Review.

PMID:
16753028
32.

The molecular mechanisms of classic Hodgkin's lymphoma.

Felberbaum RS.

Yale J Biol Med. 2005 Jul;78(4):203-10. Review.

33.

Assisted reproductive technology in Europe, 2002. Results generated from European registers by ESHRE.

European IVF-monitoring programme (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG.

Hum Reprod. 2006 Jul;21(7):1680-97. Epub 2006 Apr 3.

PMID:
16585126
34.

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol.

Griesinger G, Dawson A, Schultze-Mosgau A, Finas D, Diedrich K, Felberbaum R.

Fertil Steril. 2006 Mar;85(3):791-3.

PMID:
16500366
35.

Cost restricts the value of recombinant FSH.

Felberbaum R.

Reprod Biomed Online. 2005 Nov;11(5):544. No abstract available.

PMID:
16409699
36.

Breastfeeding duration is determined by only a few factors.

Peters E, Wehkamp KH, Felberbaum RE, Krüger D, Linder R.

Eur J Public Health. 2006 Apr;16(2):162-7. Epub 2005 Oct 5.

PMID:
16207725
37.

Why do couples refuse or discontinue ART?

Dawson AA, Diedrich K, Felberbaum RE.

Arch Gynecol Obstet. 2005 Nov;273(1):3-11. Epub 2005 Oct 28. Review.

PMID:
16080011
38.

GnRH-antagonists in reproductive medicine.

Griesinger G, Felberbaum R, Diedrich K.

Arch Gynecol Obstet. 2005 Dec;273(2):71-8. Epub 2005 Jul 1. Review.

PMID:
15991015
39.

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry.

Griesinger G, Felberbaum R, Diedrich K.

Hum Reprod. 2005 Sep;20(9):2373-5. Epub 2005 Jun 2.

PMID:
15932915
40.

To agonize or antagonize in gonadotrophin stimulation cycles?

Felberbaum RE, Griesinger G, Finas D, Dawson A, Diedrich K.

Reprod Biomed Online. 2005 Jun;10 Suppl 3:33-6.

PMID:
23577413
41.

Mayer-Rokitansky-Küster-Hauser syndrome associated with thrombocytopenia-absent radius syndrome.

Griesinger G, Dafopoulos K, Schultze-Mosgau A, Schroder A, Felberbaum R, Diedrich K.

Fertil Steril. 2005 Feb;83(2):452-4.

PMID:
15705390
42.

Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE.

Andersen AN, Gianaroli L, Felberbaum R, de Mouzon J, Nygren KG; European IVF-monitoring programme (EIM), European Society of Human Reproduction and Embryology (ESHRE).

Hum Reprod. 2005 May;20(5):1158-76. Epub 2005 Jan 21.

PMID:
15665021
43.

Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.

Griesinger G, Schultze-Mosgau A, Dafopoulos K, Schroeder A, Schroer A, von Otte S, Hornung D, Diedrich K, Felberbaum R.

Hum Reprod. 2005 May;20(5):1200-6. Epub 2005 Jan 21.

PMID:
15665010
44.

FSH time-concentration profiles before and after administration of 0.25 mg cetrorelix in the gnRH-antagonist multiple-dose protocol for ovarian hyperstimulation.

Griesinger G, Finas D, Alisch A, Roiha K, Schultze-Mosgau A, Schröder AK, Dafopoulos K, Diedrich K, Felberbaum R.

J Assist Reprod Genet. 2004 Jul;21(7):279-82.

45.

Additive effect of steroids and cholesterol on the liposomal transfection of the breast cancer cell line T-47D.

Köster F, Finas D, Schulz C, Hauser C, Diedrich K, Felberbaum R.

Int J Mol Med. 2004 Oct;14(4):769-72.

PMID:
15375616
46.

What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?

Griesinger G, Dafopoulos K, Schultze-Mosgau A, Felberbaum R, Diedrich K.

Hum Reprod. 2004 Jun;19(6):1239-41. Epub 2004 Apr 22.

PMID:
15105385
47.

Taxanes in the first-line chemotherapy of metastatic breast cancer: review.

Friedrich M, Diesing D, Villena-Heinsen C, Felberbaum R, Kolberg HC, Diedrich K.

Eur J Gynaecol Oncol. 2004;25(1):66-70. Review.

PMID:
15053065
48.

Previous miscarriages influence IVF and intracytoplasmatic sperm injection pregnancy outcome.

Kupka MS, Dorn C, Montag M, Felberbaum RE, van der Ven H, Kulczycki A, Friese K.

Reprod Biomed Online. 2004 Mar;8(3):349-57.

PMID:
15038904
49.

Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

Griesinger G, Felberbaum RE, Schultze-Mosgau A, Diedrich K.

Drugs. 2004;64(6):563-75. Review.

PMID:
15018588
50.

Ductal carcinoma in situ of the breast: diagnosis and management.

Friedrich M, Felberbaum R, Krämer S, Axt-Fliedner R, Diedrich K.

Onkologie. 2003 Dec;26(6):588-95. Review.

PMID:
14709936

Supplemental Content

Loading ...
Support Center